Neptune Generics, LLC v. Eli Lilly & Co. (Fed. Cir. 2019)

By Donald Zuhn -- Last week, in Neptune Generics, LLC v. Eli Lilly & Co., the Federal Circuit affirmed a determination by the U.S. Patent and Trademark Office Patent Trial and Appeal Board in an inter partes review that claims 1-22 of U.S. Patent No. 7,772,209 were not unpatentable for obviousness. ...

patentdocs.org